Maa: Yhdistynyt kuningaskunta
Kieli: englanti
Lähde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Neostigmine bromide
Alliance Pharmaceuticals Ltd
N07AA01
Neostigmine bromide
15mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10020100; GTIN: 5024403000240
PATIENT INFORMATION LEAFLET NEOSTIGMINE BROMIDE 15 MG TABLETS Neostigmine bromide READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. • KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. • IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR OR PHARMACIST. • THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. DO NOT PASS IT ON TO OTHERS. IT MAY HARM THEM, EVEN IF THEIR SYMPTOMS ARE THE SAME AS YOURS. • IF ANY OF THE SIDE EFFECTS GETS SERIOUS, OR IF YOU NOTICE ANY SIDE EFFECTS NOT LISTED IN THIS LEAFLET, PLEASE TELL YOUR DOCTOR OR PHARMACIST. IN THIS LEAFLET: 1. WHAT NEOSTIGMINE BROMIDE TABLETS ARE AND WHAT THEY ARE USED FOR 2. BEFORE YOU TAKE NEOSTIGMINE BROMIDE TABLETS 3. HOW TO TAKE NEOSTIGMINE BROMIDE TABLETS 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE NEOSTIGMINE BROMIDE TABLETS 6. FURTHER INFORMATION 1. WHAT NEOSTIGMINE BROMIDE TABLETS ARE AND WHAT THEY ARE USED FOR Neostigmine Bromide Tablets block the action of an enzyme in the body which “switches off” nerve impulses to muscles. By stopping this enzyme from working, Neostigmine Bromide can increase muscle strength, but only in certain conditions. Neostigmine Bromide Tablets are used mainly for the treatment of myasthenia gravis, a disease in which the muscles are weak and tire easily. They are also used when the normal movements of the intestine are absent and for the treatment of urinary retention after surgery. 2. BEFORE YOU TAKE NEOSTIGMINE BROMIDE TABLETS YOU SHOULD NOT TAKE THESE TABLETS IF: • You have a blockage in your intestine which may cause vomiting, abdominal pain and swelling • You have difficulty passing water • You know that you are allergic to Neostigmine Bromide or any of the other ingredients in Section 6 of this leaflet Make sure your doctor knows if any of these apply to you before you take these tablets. BEFORE YOU TAKE NEOSTIGMINE BROMIDE TABLETS, YOUR DOCTOR WILL TAKE SPECIAL ARE IF ANY OF THE FOLLOWING APPLY TO YOU: • You suffer from asthma • You have a stomach ulcer Neostigmine PIL UK 003 • You suffer Lue koko asiakirja
OBJECT 1 NEOSTIGMINE BROMIDE TABLETS15MG Summary of Product Characteristics Updated 10-Feb-2015 | Alliance Pharmaceuticals 1. Name of the medicinal product Neostigmine Bromide Tablets 15 mg 2. Qualitative and quantitative composition Each tablet contains 15 mg neostigmine bromide Ph.Eur. 3. Pharmaceutical form Tablets 4. Clinical particulars 4.1 Therapeutic indications Myasthenia gravis; paralytic ileus; post-operative urinary retention. 4.2 Posology and method of administration Neostigmine bromide has a slower onset of effect when given orally than when given parenterally, but the duration of action is longer and the intensity of action more uniform. To facilitate change of treatment from one route of administration to another, the following doses are approximately equivalent in effect: 0.5 mg intravenously = 1-1.5 mg intramuscularly or subcutaneously = 15 mg orally. Myasthenia gravis _Adults_: Doses of 1-2 tablets by mouth are given at intervals throughout the day when maximum strength is needed (for example, on rising and before mealtimes). The usual duration of action of a dose is two to four hours. The total daily dose is usually in the range of 5-20 tablets but doses higher than these may be needed by some patients. _Newborn infants_: Neostigmine bromide ampoules are recommended. _Older children_: Children under 6 years old should receive an initial dose of half a tablet (7.5 mg) of Neostigmine Bromide; children 6-12 years old should receive one tablet (15 mg). Dosage requirements should be adjusted according to the response but are usually in the range of 15-90 mg orally per day. The requirement for Neostigmine Bromide is usually markedly decreased after thymectomy, or when additional therapy (steroids, immunosuppressant drugs) is given. When relatively large doses of neostigmine bromide are taken by myasthenic patients, it may be necessary to give atropine or other anticholinergic drugs to counteract the muscarinic effects. It should be noted that the slower gastro-intestinal motility caused by these drug Lue koko asiakirja